A wealth of literature has linked MAO-A to prostate cancer growth, metastasis, and therapy resistance via numerous mechanisms including oxidative stress, hypoxia, epithelial-to-mesenchymal transition, and modulation of the tumor microenvironment [32]. The gene discussed is MAOA; the disease is neoplasm.